Skip to main content
. 2021 Jun 28;11(11):2796–2811. doi: 10.1158/2159-8290.CD-20-1647

Figure 1.

Figure 1. Study design. Illustration of the design of the AURORA molecular screening program including the baseline and longitudinal collections of samples as well as the clinical data. ctDNA, circulating tumor DNA.

Study design. Illustration of the design of the AURORA molecular screening program including the baseline and longitudinal collections of samples as well as the clinical data. ctDNA, circulating tumor DNA.